Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Crescent Biopharma (CBIO) Return on Capital Employed (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Return on Capital Employed for 10 consecutive years, with 0.92% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed changed N/A to 0.92% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.92% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.94% for FY2023, 20.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.92% at Crescent Biopharma, down from 0.41% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.41% in Q3 2025, with the low at 3.22% in Q1 2025.
  • Average Return on Capital Employed over 5 years is 1.02%, with a median of 0.85% recorded in 2022.
  • Peak annual rise in Return on Capital Employed hit 173bps in 2025, while the deepest fall reached -208bps in 2025.
  • Over 5 years, Return on Capital Employed stood at 0.71% in 2021, then crashed by -48bps to 1.05% in 2022, then grew by 12bps to 0.93% in 2023, then plummeted by -131bps to 2.14% in 2024, then surged by 57bps to 0.92% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.92%, 0.41%, and 0.56% for Q4 2025, Q3 2025, and Q2 2025 respectively.